T 0325/19 (Adeno-Associated Virus (AAV) serotype 8/THE TRUSTEES OF THE … of 9.1.2024

European Case Law Identifier: ECLI:EP:BA:2024:T032519.20240109
Date of decision: 09 January 2024
Case number: T 0325/19
Application number: 02795539.2
IPC class: A61K 48/00
C12N 5/10
C12N 7/01
C12N 7/04
C12N 15/63
C12N 15/64
C12N 15/864
C07H 21/04
C07K 14/015
C07K 7/04
C07K 7/06
C07K 7/08
Language of proceedings: EN
Distribution: D
Download and more information:
Decision text in EN (PDF, 254 KB)
Documentation of the appeal procedure can be found in the Register
Bibliographic information is available in: EN
Versions: Unpublished
Title of application: Adeno-Associated Virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor
Applicant name: The Trustees of The University of Pennsylvania
Opponent name: Vossius & Partner
Patentanwälte Rechtsanwälte mbB
Board: 3.3.08
Headnote: -
Relevant legal provisions:
European Patent Convention Art 113(2)
Keywords: Basis of decision - text or agreement to text withdrawn by patent proprietor
Catchwords:

-

Cited decisions:
T 0073/84
T 0186/84
T 0646/08
T 2434/18
Citing decisions:
-

Summary of Facts and Submissions

I. Both parties to the proceedings (the patent proprietor and the opponent) lodged an appeal against the interlocutory decision of an opposition division according to which European patent No. 1 453 547 ("the patent") could be maintained in amended form.

II. With their statement of grounds of appeal, appellant I (patent proprietor) submitted inter alia a main request and 29 auxiliary requests (auxiliary requests 1, 1A, and 2 to 28) and requested inter alia that the patent be maintained on the basis of the main request, or in the alternative on the basis of auxiliary requests 1, 1A or 2 to 28.

III. With their statement of grounds of appeal, appellant II (opponent) requested inter alia that the decision under appeal be set aside and the patent be revoked.

IV. The board appointed oral proceedings and, in a subsequent communication pursuant to Article 15(1) RPBA 2020, provided its preliminary appreciation of some matters concerning the appeal.

V. In their letters dated 11 December 2023 and 14 December 2023, appellant I declared that they no longer approved the text of the patent as granted, and that they withdrew all auxiliary requests on file.

Reasons for the Decision

1. Pursuant to the principle of party disposition established by Article 113(2) EPC, the EPO shall examine, and decide upon, the European patent only in the text submitted to it, or agreed, by the proprietor of the patent.

2. In the present case, the patent proprietor no longer approves of the text in which the patent was granted. Furthermore, it has withdrawn all its pending requests (see letters dated 11 and 14 December 2023). There is thus no approved text on the basis of which the board could consider the appeals of the opponent and examine whether a ground for opposition prejudices the maintenance of the patent. It is also no longer possible to take a decision as to substance because the absence of an approved text precludes any substantive examination of the alleged impediments to patentability (T 186/84, OJ 1986, 79, point 5 of the Reasons;

T 646/08, point 4 of the Reasons and T 2434/18, point 4 of the Reasons).

3. According to the case law of the boards of appeal, in these circumstances the proceedings are to be terminated by a decision ordering revocation of the patent under Article 101 EPC without assessing issues relating to patentability since the patent proprietor no longer challenges the request for revocation of the opposed patent, and the patent cannot be maintained against the proprietor's will (see decision T 73/84, OJ EPO 1985, 241, and Case Law of the Boards of Appeal of the European Patent Office, 10th edition 2022, III.B.3.3).

4. There are no remaining issues that need to be dealt with by the board in the present appeal case.

Order

For these reasons it is decided that:

The decision under appeal is set aside.

The patent is revoked.

Quick Navigation